Free Trial

Scancell (LON:SCLP) Trading 16.1% Higher - Here's What Happened

Scancell logo with Medical background

Scancell Holdings plc (LON:SCLP - Get Free Report) shares were up 16.1% on Monday . The company traded as high as GBX 11 ($0.15) and last traded at GBX 9.84 ($0.13). Approximately 4,136,019 shares traded hands during trading, an increase of 410% from the average daily volume of 810,293 shares. The stock had previously closed at GBX 8.48 ($0.11).

Scancell Price Performance

The company has a quick ratio of 13.01, a current ratio of 3.42 and a debt-to-equity ratio of -566.79. The firm's 50-day moving average is GBX 8.58 and its 200-day moving average is GBX 10.80. The company has a market cap of £109.27 million, a PE ratio of -16.18 and a beta of 0.35.

Scancell (LON:SCLP - Get Free Report) last announced its earnings results on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) earnings per share (EPS) for the quarter. On average, equities analysts anticipate that Scancell Holdings plc will post -2.5361112 EPS for the current year.

About Scancell

(Get Free Report)

Scancell LSE: SCLP is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers. Scancell has developed a pipeline of ‘off-the-shelf' vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.

Further Reading

Should You Invest $1,000 in Scancell Right Now?

Before you consider Scancell, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Scancell wasn't on the list.

While Scancell currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market
Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines